SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Fredolini Claudia)
 

Search: WFRF:(Fredolini Claudia) > (2020-2024) > Clinical proteomics...

Clinical proteomics and molecular pathology

Liotta, Lance A. (author)
Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, United States
Davis, Justin B. (author)
Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, United States
Zhou, Weidong (author)
Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, United States
show more...
Petricoin, Emanuel (author)
Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, United States
Espina, Virginia (author)
Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, United States
Couch, Robin D. (author)
Department of Chemistry and Biochemistry, George Mason University, Manassas, VA, United States
Fredolini, Claudia (author)
KTH,Science for Life Laboratory, SciLifeLab,Affinitets-proteomik
show less...
 (creator_code:org_t)
Elsevier BV, 2020
2020
English.
In: Essential Concepts in Molecular Pathology. - : Elsevier BV. ; , s. 149-163
  • Book chapter (other academic/artistic)
Abstract Subject headings
Close  
  • Genomic and proteomic research is launching the next era of cancer molecular medicine. Molecular expression profiles can uncover clues to functionally important molecules in the development of human disease and generate information to subclassify human tumors and tailor a treatment to the individual patient. The next revolution is the synthesis of proteomic information into functional pathways and circuits in cells and tissues. Such synthesis must take into account the dynamic state of protein post-translational modifications; protein-protein or protein-DNA/RNA interactions; cross-talk between signal pathways; and feedback regulation within cells, between cells, and between tissues. This full set of information may be required before we can fully dissect the specific dysregulated pathways driving tumorigenesis. This higher level of functional understanding will be the basis for true rational therapeutic design that specifically targets the molecular lesions underlying human disease.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)

Keyword

Analyte
Antibody
Biomarker
Microdissection
Proteomics
Tumorigenesis

Publication and Content Type

vet (subject category)
kap (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view